Cumulative Samples for Gut Microbiome Testing Exceed 250,000!
Saikinso announced that its cumulative samples for the 'Mykinso' gut microbiome testing service reached 250,000 as of April 2026. Since commercializing the service in 2015, the company has built one of Japan's largest datasets, which it will continue to leverage to realize a 'zero-order prevention society.'
📋 Article Processing Timeline
- 📰 Published: May 22, 2026 at 19:00
- 🔍 Collected: May 22, 2026 at 10:31
- 🤖 AI Analyzed: May 22, 2026 at 11:07 (35 min after Collected)
Saikinso, a company with the corporate philosophy of 'improving human health through microbiomes' (Headquarters: Shibuya-ku, Tokyo; Representative Director: Yosuke Hara), announced that its cumulative sample count for the 'Mykinso' gut microbiome testing service surpassed 250,000 as of April 2026.
Saikinso pioneered the commercialization of gut microbiome testing for individuals in Japan in 2015 and has since expanded the 'Mykinso' series. With the increasing recognition of the importance of the gut environment for health maintenance, the number of samples reached 250,000 in just about nine months since surpassing 200,000 in July 2025, accelerating its growth.
The 250,000 samples represent one of the largest databases in Japan and globally. These data serve as crucial assets for unraveling the health conditions of the Japanese population across diverse lifestyles, significantly enhancing the value of data utilization in academic research and business settings.
The company has built a massive data foundation through consumer testing and solutions for enterprises and research institutions. Moving forward, it will leverage these data assets to develop businesses aimed at realizing a 'zero-order prevention society.'
Saikinso's Data-Driven Initiatives:
- All-in-one Gut Activity App 'Floreco by Mykinso'
Released in November 2025, this app integrates gut microbiome data with professional insights to help beginners and those verifying gut-health effects habituate optimal gut activities for consistent health maintenance.
- Research Support App 'Mykinso Explorer'
Launched in April 2026, this B2B app allows for the analysis of microbiome data combined with lifestyle data. It enables rapid hypothesis testing and an understanding of gut environmental characteristics for target audiences, expanding its use in product planning and marketing design.
- Strengthening 'Health & Productivity Management Support Services' for Corporations
The company is enhancing solutions that contribute to employees' mental and physical health and organizational productivity through its corporate services.
Every 26th is 'Flora Day'
To make gut microbiomes more accessible, Saikinso has designated the 26th of every month as 'Flora Day' and conducts regular campaigns.
In May 2026, to express gratitude for reaching 250,000 samples, the company is holding a '20x Points Campaign' at the Mykinso Store.
Campaign period: May 20, 2026 (Wed) 12:00 to May 27, 2026 (Wed) 12:00.
Saikinso pioneered the commercialization of gut microbiome testing for individuals in Japan in 2015 and has since expanded the 'Mykinso' series. With the increasing recognition of the importance of the gut environment for health maintenance, the number of samples reached 250,000 in just about nine months since surpassing 200,000 in July 2025, accelerating its growth.
The 250,000 samples represent one of the largest databases in Japan and globally. These data serve as crucial assets for unraveling the health conditions of the Japanese population across diverse lifestyles, significantly enhancing the value of data utilization in academic research and business settings.
The company has built a massive data foundation through consumer testing and solutions for enterprises and research institutions. Moving forward, it will leverage these data assets to develop businesses aimed at realizing a 'zero-order prevention society.'
Saikinso's Data-Driven Initiatives:
- All-in-one Gut Activity App 'Floreco by Mykinso'
Released in November 2025, this app integrates gut microbiome data with professional insights to help beginners and those verifying gut-health effects habituate optimal gut activities for consistent health maintenance.
- Research Support App 'Mykinso Explorer'
Launched in April 2026, this B2B app allows for the analysis of microbiome data combined with lifestyle data. It enables rapid hypothesis testing and an understanding of gut environmental characteristics for target audiences, expanding its use in product planning and marketing design.
- Strengthening 'Health & Productivity Management Support Services' for Corporations
The company is enhancing solutions that contribute to employees' mental and physical health and organizational productivity through its corporate services.
Every 26th is 'Flora Day'
To make gut microbiomes more accessible, Saikinso has designated the 26th of every month as 'Flora Day' and conducts regular campaigns.
In May 2026, to express gratitude for reaching 250,000 samples, the company is holding a '20x Points Campaign' at the Mykinso Store.
Campaign period: May 20, 2026 (Wed) 12:00 to May 27, 2026 (Wed) 12:00.
FAQ
サイキンソーの腸内フローラ検査の累計検体数はどのくらいですか？
2026年4月時点で累計25万件を突破しました。
サイキンソーはどのようなサービスを展開していますか？
個人向け腸内フローラ検査「Mykinso」、法人・研究機関向けソリューション、オールインワン腸活アプリ「フロレコ by マイキンソー」、研究支援アプリ「Mykinso Explorer」などを展開しています。
「Mykinso Explorer」とはどのようなサービスですか？
2026年4月から提供を開始したBtoB向けアプリで、菌叢データと生活者データを掛け合わせて分析できるため、研究開発や商品企画などに活用可能です。
毎月26日は何の日ですか？
サイキンソーでは、毎月26日を「フローラの日」と定め、定期的なキャンペーンを実施しています。
25万検体突破を記念したキャンペーンの詳細は？
Mykinso Storeにて、検査キット購入時に通常の20倍となる3,600ポイントを付与するほか、5月26日当日限定のガチャ企画を実施します。期間は2026年5月20日から27日までです。